Even if they come back they may not be listed, especially if the recap brings in new equity and new shareholders. Getting 5c on the dollar is even an optimistic case for current holders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025